Jubilant Pharma Limited
Jubilant Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in Singapore (SG) and operates extensively across North America, Europe, and Asia. Founded in 2007, the company has rapidly established itself as a leader in contract manufacturing and pharmaceutical services, focusing on areas such as sterile injectables, radiopharmaceuticals, and drug delivery systems. Jubilant Pharma is renowned for its innovative core products, which include a diverse range of high-quality generic and branded pharmaceuticals. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships. With a robust portfolio and a dedication to advancing healthcare solutions, Jubilant Pharma continues to make significant strides in the global pharmaceutical landscape.
DitchCarbon Score
How does Jubilant Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jubilant Pharma Limited's score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jubilant Pharma Limited's reported carbon emissions
Jubilant Pharma Limited, headquartered in Singapore (SG), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their current impact on climate change or their strategic approach to reducing carbon emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate strategy or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Jubilant Pharma to establish clear targets and transparent reporting to align with global climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jubilant Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
